AtaiBeckley Inc. recently announced that the last patient has been dosed in Elumina, its 156-patient, international Phase 2b ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results